Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment

British Journal of Psychiatry

Volumn 170, Issue JUNE, 1997, Pages 554-557

  Monteleone, Palmiero ^a,b   Catapano, Francesco ^a   Di Martino, Stefania ^a   Ferraro, Ciro ^a   Maj, Mario ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Primo Policlinico Universitario   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; FLUVOXAMINE; PLACEBO; PROLACTIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPULSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MENTAL DISEASE; NEUROSIS; OBSESSION; PROLACTIN RELEASE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC TRANSMISSION; TREATMENT OUTCOME;

EID: 0030774688     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.170.6.554     Document Type: Article

References (13)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.
2. Bastani, B., Nash, F. & Meltzer, H. Y. (1990) Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder. Archives of General Psychiatry, 47, 833-839.
3. Goodman, W. K., Price, L. H., Rasmussen, S. A., et al (1989) The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS): I. Development, use and reliability. Archives of General Psychiatry 46, 1006-1011.
4. Gorard, D. A., Taylor, T. M., Medbak, S. H., et al (1993) Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo in healthy subjects. International Clinical Psychopharmacology, 8, 123-128.
5. Hamilton, M. A. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.
6. Hollander, E., DéCaria, C. M., Nitescu, A., et al (1992) Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Archives of General Psychiatry, 49, 21-28.
7. Lucey, J. V., O'Keane, V., Butcher, G., et al (1992) Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls. British Journal of Psychiatry, 161, 517-521.
8. _ , Butcher, G., Clare, A.W., et al (1993) The anterior pituitary responds normally to proterilin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit. Acta Psychiatrica Scandinavica, 87, 384-388.
9. McBride, P. A., Tierney, H., DeMeo, M., et al (1990) Effects of age and gender on CNS serotonergic responsivity in normal adults. Biological Psychiatry, 27, 1143-1155.
10. O'Keane, V., O'Hanlon, M., Webb, M., et al (1991) D-fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration. Clinical Endocrinology, 34, 289-292.
11. Roberts, A., Finberg, N. A., Montgomery, S. A., et al (1996) Increased prolactin responses to d-fenfluramine in patients with obsessive-compulsive disorder. Journal of Psychopharmacology, 10 (suppl. 3), A37.
12. Swedo, S. E., Leonard, H. L., Kruesi, M. J., et al (1992) Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Archives of General Psychiatry, 49, 29-36.
13. Thorén, P., Asberg, M., Bertilsson, L., et al (1980) Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects. Archives of General Psychiatry, 37, 1289-1294.